February 10, 2023
FDA: Class I recall of Smiths Medical CADD Infusion System Administration Sets, Cassette Reservoirs
Editor's Note
The Food and Drug Administration (FDA) on February 2 identified the recall by Smiths Medical of certain CADDTM Infusion System Administration Sets and Cassette Reservoirs as Class I, the most serious.
The recall was initiated because of tubing occlusion and false “no disposable attached” alarm issues, which may cause delays, interruptions, or under delivery of therapy.
Smith Medical reports that there have been 1,571 incidents, 14 injuries, and 2 deaths related to tubing occlusion and 9,101 incidents, 11 injuries, and no deaths related to false alarm issues.
Distribution dates were June 15, 2018, to present.
Free Daily News
- Routine preop tests catch hidden risks in outpatient cosmetic surgery, Canadian study finds
- Study: Hospital same‑day knee replacements match ASC outcomes, even in higher‑risk patients
- FDA clears AI platform for real-time surgical measurements
- Study: MRI contrast agent causes harmful metal buildup in some patients
- Dissolvable pacemaker delivers temporary cardiac support without wires, surgery
- CSA taps Milagro’s AI coding to accelerate revenue cycle across ASC network
- Study: Cannabis use complicates sedation, cancer care
- Medication vial coring incidents prompt patient safety concerns
- First single-port robotic renal vein transposition surgery treats nutcracker syndrome
- Study: Mortality prediction models fail to recognize severe patient injuries
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement